Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Formula information collection

This article was originally published in The Tan Sheet

Executive Summary

FDA receives the Office of Management and Budget's clearance for its "Infant Formula Requirements" collection of information, the agency says June 21. In the supporting statement it submitted to OMB, FDA says executing regulatory control over the formulation and production of infant formula requires assuring that each batch of a manufacturer's formula is uniform in composition and conforms to known nutrient requirements. In an additional effort to detect noncompliance with formula manufacturing regulations, the information collection is needed to determine whether unauthorized reformulations have occurred. OMB approved the information collection for use through June 2010...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS100635

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel